Total Payments
$277,888
2024 Payments
$57,824
Companies
43
Transactions
636
Medicare Patients
211
Medicare Billing
$27,643
Payment Breakdown by Category
Other$183,161 (65.9%)
Consulting$54,404 (19.6%)
Travel$26,884 (9.7%)
Food & Beverage$13,210 (4.8%)
Education$229.31 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $147,691 | 59 | 53.1% |
| Consulting Fee | $54,404 | 17 | 19.6% |
| Honoraria | $35,470 | 11 | 12.8% |
| Travel and Lodging | $26,884 | 108 | 9.7% |
| Food and Beverage | $13,210 | 434 | 4.8% |
| Education | $229.31 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Grifols USA, LLC | $102,963 | 138 | $0 (2024) |
| ARGENX US, INC. | $57,657 | 56 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $53,301 | 47 | $0 (2024) |
| CSL Behring | $41,042 | 60 | $0 (2024) |
| Shire North American Group Inc | $8,600 | 10 | $0 (2019) |
| Grifols Shared Services North America, Inc. | $5,069 | 3 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $3,759 | 27 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $872.57 | 73 | $0 (2023) |
| GENZYME CORPORATION | $496.54 | 25 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $385.36 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57,824 | 80 | ARGENX US, INC. ($36,900) |
| 2023 | $51,549 | 91 | Grifols USA, LLC ($18,150) |
| 2022 | $48,611 | 57 | Grifols USA, LLC ($22,812) |
| 2021 | $22,756 | 31 | Takeda Pharmaceuticals U.S.A., Inc. ($12,260) |
| 2020 | $17,766 | 36 | CSL Behring ($8,434) |
| 2019 | $23,958 | 91 | Grifols USA, LLC ($9,442) |
| 2018 | $37,387 | 157 | CSL Behring ($28,449) |
| 2017 | $18,036 | 93 | Grifols USA, LLC ($16,971) |
All Payment Transactions
636 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Neurology | ||||||
| 11/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.14 | General |
| 10/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: Immunology and Neurology | ||||||
| 10/08/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Immunology | ||||||
| 10/02/2024 | ARGENX US, INC. | VYVGART (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,437.50 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ARGENX US, INC. | VYVGART (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,625.00 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,990.00 | General |
| Category: Immunology and Neurology | ||||||
| 09/20/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | In-kind items and services | $429.70 | General |
| Category: Immunology and Neurology | ||||||
| 09/20/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | In-kind items and services | $361.19 | General |
| Category: Immunology and Neurology | ||||||
| 09/20/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $105.70 | General |
| Category: Immunology and Neurology | ||||||
| 09/20/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | Cash or cash equivalent | $97.80 | General |
| Category: Immunology and Neurology | ||||||
| 09/20/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Travel and Lodging | Cash or cash equivalent | $54.00 | General |
| Category: Immunology and Neurology | ||||||
| 09/20/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | Cash or cash equivalent | $9.02 | General |
| Category: Immunology and Neurology | ||||||
| 09/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Rare Disease | ||||||
| 08/19/2024 | ARGENX US, INC. | VYVGART (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,625.00 | General |
| Category: Immunology | ||||||
| 08/19/2024 | ARGENX US, INC. | VYVGART (Drug) | Travel and Lodging | Cash or cash equivalent | $269.34 | General |
| Category: Immunology | ||||||
| 08/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Immunology | ||||||
| 08/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $58.76 | General |
| Category: Immunology | ||||||
| 08/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Immunology | ||||||
| 08/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Immunology | ||||||
| 08/03/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 72 | $21,236 | $6,737 |
| 2022 | 4 | 82 | 105 | $33,144 | $11,385 |
| 2021 | 1 | 25 | 38 | $9,348 | $3,075 |
| 2020 | 3 | 53 | 71 | $19,632 | $6,446 |
Total Patients
211
Total Services
286
Medicare Billing
$27,643
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 38 | $10,944 | $3,493 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,042 | $2,136 | 30.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 12 | 20 | $3,250 | $1,108 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 45 | $11,466 | $4,223 | 36.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $10,682 | $3,453 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 16 | $6,220 | $1,982 | 31.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 13 | 22 | $4,776 | $1,726 | 36.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 38 | $9,348 | $3,075 | 32.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 35 | $8,610 | $2,594 | 30.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $6,123 | $2,059 | 33.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 15 | 23 | $4,899 | $1,794 | 36.6% |
About Dr. John England, MD
Dr. John England, MD is a Neurology healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427169283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John England, MD has received a total of $277,888 in payments from pharmaceutical and medical device companies, with $57,824 received in 2024. These payments were reported across 636 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($147,691).
As a Medicare-enrolled provider, England has provided services to 211 Medicare beneficiaries, totaling 286 services with total Medicare billing of $27,643. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location New Orleans, LA
- Active Since 08/31/2006
- Last Updated 11/04/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1427169283
Products in Payments
- Gamunex-C (Biological) $95,587
- VYVGART (Drug) $53,714
- GAMMAGARD LIQUID (Biological) $42,427
- Hizentra (Biological) $41,042
- Xembify (Biological) $12,446
- HYQVIA (Biological) $9,113
- VYVGART HYTRULO (Drug) $3,921
- GAMMAGARD (Biological) $3,691
- SOLIRIS (Drug) $600.20
- COPAXONE (Drug) $389.43
- NUPLAZID (Drug) $325.03
- Briviact (Drug) $305.15
- GOCOVRI (Drug) $269.31
- KESIMPTA (Drug) $260.27
- TYSABRI (Biological) $252.47
- LEMTRADA (Drug) $238.66
- AUSTEDO (Drug) $211.18
- Aimovig (Biological) $181.39
- AJOVY (Drug) $160.66
- ZEPOSIA (Drug) $150.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in New Orleans
Fawad Khan, Md, M.b.b.s, MD, M.B.B.S
Neurology — Payments: $441,789
Neurology $441,789
Brian Copeland, Md, MD
Neurology — Payments: $238,080
Neurology $238,080
Dr. Sheryl Martin-Schild, Md, Phd, MD, PHD
Neurology — Payments: $169,227
Neurology $169,227
Dr. Elizabeth Crabtree, M.d, M.D
Neurology — Payments: $114,250
Neurology $114,250
Bridget Bagert, Md, MD
Neurology — Payments: $101,540
Neurology $101,540
Piotr Olejniczak, Md, MD
Neurology — Payments: $79,582
Neurology $79,582